A Chemical-Genetic Approach to Studying Neurotrophin Signaling

Trk tyrosine kinases are receptors for members of the neurotrophin family and are crucial for growth and survival of specific populations of neurons. Yet, the functions of neurotrophin-Trk signaling in postnatal development as well as maintenance and plasticity of the adult nervous system are less clear. We report here the generation of mice harboring Trk knockin alleles that allow for pharmacological control of Trk kinase activity. Nanomolar concentrations of either 1NMPP1 or 1NaPP1, derivatives of the general kinase inhibitor PP1, inhibit NGF and BDNF signaling in TrkA(F592A) and TrkB(F616A) neurons, respectively, while no such Trk inhibition is observed in wild-type neurons. Moreover, oral administration of 1NMPP1 leads to specific inhibition of TrkA(F592A), TrkB(F616A), and TrkC(F167A) signaling in vivo. Thus, Trk knockin mice provide valuable tools for selective, rapid, and reversible inhibition of neurotrophin signaling in vitro and in vivo.

[1]  M. Greenberg,et al.  Membrane depolarization and calcium influx stimulate MEK and MAP kinase via activation of Ras , 1994, Neuron.

[2]  A. Saltiel,et al.  Inhibition of the cellular actions of nerve growth factor by staurosporine and K252A results from the attenuation of the activity of the trk tyrosine kinase. , 1992, Biochemistry.

[3]  H. Thoenen,et al.  Biochemical effects of antibodies against nerve growth factor on developing and differentiated sympathetic ganglia , 1978, Brain Research.

[4]  D. Ginty,et al.  Spatially and Functionally Distinct Roles of the PI3-K Effector Pathway during NGF Signaling in Sympathetic Neurons , 2000, Neuron.

[5]  R. Levi‐montalcini,et al.  Destruction of the sympathetic ganglia in mammals by an antiserum to a nerve-growth protein* , 1960, Proceedings of the National Academy of Sciences.

[6]  Chao Zhang,et al.  Control of landmark events in meiosis by the CDK Cdc28 and the meiosis-specific kinase Ime2. , 2003, Genes & development.

[7]  Philippe P Roux,et al.  K252a and CEP1347 Are Neuroprotective Compounds That Inhibit Mixed-lineage Kinase-3 and Induce Activation of Akt and ERK* , 2002, The Journal of Biological Chemistry.

[8]  P. Lazarovici,et al.  K-252a: a specific inhibitor of the action of nerve growth factor on PC 12 cells , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  A. Davies,et al.  Developmental changes in NT3 signalling via TrkA and TrkB in embryonic neurons. , 1995, The EMBO journal.

[10]  D. Ginty,et al.  A Neurotrophin Signaling Cascade Coordinates Sympathetic Neuron Development through Differential Control of TrkA Trafficking and Retrograde Signaling , 2004, Cell.

[11]  M. Barbacid,et al.  Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene , 1994, Nature.

[12]  G. Borasio.  Differential effects of the protein kinase inhibitor K-252a on the in vitro survival of chick embryonic neurons , 1990, Neuroscience Letters.

[13]  L C Katz,et al.  Neurotrophins and synaptic plasticity. , 1999, Annual review of neuroscience.

[14]  C. Murakata,et al.  K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases. , 1987, Biochemical and biophysical research communications.

[15]  E. Huang,et al.  Trk receptors: roles in neuronal signal transduction. , 2003, Annual review of biochemistry.

[16]  M. Barbacid,et al.  K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. , 1992, Oncogene.

[17]  A. Fagan,et al.  TrkA, But Not TrkC, Receptors Are Essential for Survival of Sympathetic Neurons In Vivo , 1996, The Journal of Neuroscience.

[18]  Y. Nonomura,et al.  K-252a, a novel microbial product, inhibits smooth muscle myosin light chain kinase. , 1988, The Journal of biological chemistry.

[19]  Joe Z Tsien,et al.  Inducible protein knockout reveals temporal requirement of CaMKII reactivation for memory consolidation in the brain , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Jaenisch,et al.  Lack of neurotrophin-3 leads to deficiencies in the peripheral nervous system and loss of limb proprioceptive afferents , 1994, Cell.

[21]  M. Barbacid,et al.  Disruption of the neurotrophin-3 receptor gene trkC eliminates la muscle afferents and results in abnormal movements , 1994, Nature.

[22]  P. Sokoloff,et al.  BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization , 2001, Nature.

[23]  D. Walsh,et al.  Heat-stable inhibitor protein derived peptide substrate analogs: phosphorylation by cAMP-dependent and cGMP-dependent protein kinases. , 1995, Biochemistry.

[24]  Reynaldo Sequerra,et al.  High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP , 2000, Nature Genetics.

[25]  R. Segal,et al.  Selectivity in neurotrophin signaling: theme and variations. , 2003, Annual review of neuroscience.

[26]  Peter G. Schultz,et al.  A chemical switch for inhibitor-sensitive alleles of any protein kinase , 2000, Nature.

[27]  M. Barbacid,et al.  Targeted disruption of the trkB neurotrophin receptor gene results in nervous system lesions and neonatal death , 1993, Cell.

[28]  E. H. Goulding,et al.  Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor , 2003, Nature Neuroscience.

[29]  A. Riccio,et al.  Apoptosis, Axonal Growth Defects, and Degeneration of Peripheral Neurons in Mice Lacking CREB , 2002, Neuron.